Juan P. Alderuccio, Md

This study is testing a new combination of two drugs, loncastuximab tesirine and rituximab, for adults with follicular lymphoma that has returned or not responded to prior treatments. The main goal is to see if this combination can lead to a complete disappearance of detectable c…